trending Market Intelligence /marketintelligence/en/news-insights/trending/_rn65qd8pwzjm-1wkkcwug2 content esgSubNav
In This List

Admedus director steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Admedus director steps down

Australia's Admedus Ltd. said Mathew Ratty resigned as a director of the company due to other commitments.

Ratty, who recently became CEO for Tech Mpire Ltd., will not stand for re-election at Admedus' annual meeting May 24. The company will search for an additional director to replace Ratty.

Admedus develops and sells healthcare technologies and devices for treating heart diseases, among others.